Phase 2 Malignant Tumor Clinical Trials
20 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 20 trials
Recruiting
Phase 2
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
Hepatocellular CarcinomaMelanomaEsophageal Adenocarcinoma+5 more
Dan Zandberg72 enrolled1 locationNCT04114136
Recruiting
Phase 2
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
Breast CancerBreast CarcinomaBreast Neoplasm+34 more
University of California, Davis86 enrolled1 locationNCT06268665
Recruiting
Phase 1Phase 2
Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors
Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue)
Shenzhen University General Hospital20 enrolled1 locationNCT07399769
Recruiting
Phase 1Phase 2
Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease
Malignant TumorHyperthyroidism, AutoimmuneCardiovascular Abnormalities
Peking Union Medical College Hospital600 enrolled1 locationNCT07400224
Recruiting
Phase 1Phase 2
Evaluation of the Safety, Tolerability and Efficacy of iNeo-Vac-R01, an Individualized mRNA Therapeutic Technology Based on Tumor Neoantigens, for Adjuvant Treatment in Patients With Biliary Malignant Tumors After Radical Resection
Biliary Malignant Tumors
Yifan Wang20 enrolled1 locationNCT07368803
Recruiting
Phase 1Phase 2
First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors
Advanced Malignant Tumors
Shanghai JMT-Bio Inc.436 enrolled1 locationNCT06877650
Recruiting
Phase 1Phase 2
A Study of LM-350 in Subjects With Advanced Solid Tumours
Malignant Tumors
LaNova Medicines Limited80 enrolled4 locationsNCT07112222
Recruiting
Phase 1Phase 2
Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors
Patients With Advanced or Metastatic Malignant Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.203 enrolled1 locationNCT07073534
Recruiting
Phase 1Phase 2
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
Ovarian CarcinomaNSCLCSCLC+5 more
Jacobio Pharmaceuticals Co., Ltd.152 enrolled1 locationNCT04686682
Recruiting
Phase 1Phase 2
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
Solid TumorGynecological Malignant Tumor
Sichuan Baili Pharmaceutical Co., Ltd.38 enrolled1 locationNCT05803018
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors
Advanced Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd468 enrolled6 locationsNCT05779163
Recruiting
Phase 1Phase 2
Study of LM-299 in Subjects Advanced Malignant Tumors
Malignant Tumors
LaNova Medicines Limited108 enrolled6 locationsNCT06650566
Recruiting
Phase 2
Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy
RadiotherapyLocal Recurrence of Malignant Tumor of Prostate
Maria Sklodowska-Curie National Research Institute of Oncology55 enrolled1 locationNCT06201078
Recruiting
Phase 2
Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk
Biliary Malignant Tumors
The First Affiliated Hospital with Nanjing Medical University70 enrolled1 locationNCT06685289
Recruiting
Phase 1Phase 2
A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors
Advanced Malignant Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.25 enrolled1 locationNCT05991583
Recruiting
Phase 1Phase 2
A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors
Malignant Tumors
LaNova Medicines Limited139 enrolled5 locationsNCT05615974
Recruiting
Phase 1Phase 2
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
Breast CancerCancer of the BreastBreast Tumor+3 more
BriaCell Therapeutics Corporation18 enrolled1 locationNCT06471673
Recruiting
Phase 1Phase 2
Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
Small Cell Lung CancerAdvanced Solid Malignant Tumor
Chipscreen Biosciences, Ltd.36 enrolled11 locationsNCT05271292
Recruiting
Phase 1Phase 2
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
Advanced Malignant Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.50 enrolled1 locationNCT06223841
Recruiting
Phase 2
A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy
MSI-H Solid Malignant Tumor
Shanghai Henlius Biotech108 enrolled33 locationsNCT03941574